Advil Liqui Gels Recalled Due to Illegible Labeling Defect
Advil Liqui Gels (200mg ibuprofen capsules) are being recalled nationwide because adhesive on the packaging migrated onto the label, causing it to tear and become illegible when peeled back.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class I, establishing a minimum severity score of 4 per the rubric. Although an illegible label on a medication could prevent proper identification or dosing, no illnesses or injuries have been reported.
Plain-English summary
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon, the manufacturer of Advil Liqui Gels, is recalling 88,380 capsules of their 200mg ibuprofen pain reliever due to a labeling defect.
The defect occurs when the adhesive used on the label migrates onto the label surface itself, causing the label to tear when consumers peel it back. This results in illegible labeling that could prevent proper product identification or dosage information.
The recall affects Advil Liqui Gels distributed nationwide in the United States. The affected lot is R94065 with an expiration date of 02/29/2024 (UPC 3 0573 0169 49 3). Pfizer in Madison, NJ is the distributor.
Consumers with affected products should discontinue use and contact the manufacturer or their healthcare provider with questions. This is a Class I recall issued by the U.S. Food and Drug Administration.
The recalled product
- Product
- Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3
- Manufacturer
- Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
- Hazard
- illegible-label
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: R94065
- Exp 02/29/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27